- Home
- APAM vs PRCT Comparison
APAM vs PRCT Comparison
Compare APAM & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APAM
- PRCT
- Stock Information
- Founded
- APAM 1994
- PRCT 2009
- Country
- APAM United States
- PRCT United States
- Employees
- APAM N/A
- PRCT N/A
- Industry
- APAM Investment Managers
- PRCT Medical Specialities
- Sector
- APAM Finance
- PRCT Health Care
- Exchange
- APAM Nasdaq
- PRCT Nasdaq
- Market Cap
- APAM 2.9B
- PRCT 3.2B
- IPO Year
- APAM 2013
- PRCT 2021
- Fundamental
- Price
- APAM $46.32
- PRCT $45.73
- Analyst Decision
- APAM Hold
- PRCT Buy
- Analyst Count
- APAM 6
- PRCT 8
- Target Price
- APAM $43.42
- PRCT $86.14
- AVG Volume (30 Days)
- APAM 611.3K
- PRCT 1.3M
- Earning Date
- APAM 07-29-2025
- PRCT 08-06-2025
- Dividend Yield
- APAM 7.64%
- PRCT N/A
- EPS Growth
- APAM 12.91
- PRCT N/A
- EPS
- APAM 3.78
- PRCT N/A
- Revenue
- APAM $1,136,529,000.00
- PRCT $249,121,000.00
- Revenue This Year
- APAM $6.76
- PRCT $47.51
- Revenue Next Year
- APAM $8.17
- PRCT $31.69
- P/E Ratio
- APAM $12.24
- PRCT N/A
- Revenue Growth
- APAM 10.03
- PRCT 59.36
- 52 Week Low
- APAM $32.75
- PRCT $45.46
- 52 Week High
- APAM $49.54
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- APAM 54.79
- PRCT 29.87
- Support Level
- APAM $43.59
- PRCT $47.13
- Resistance Level
- APAM $46.93
- PRCT $51.18
- Average True Range (ATR)
- APAM 1.13
- PRCT 3.01
- MACD
- APAM -0.13
- PRCT -0.93
- Stochastic Oscillator
- APAM 78.07
- PRCT 4.19
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.